title: Rapid selection and proliferation of CD133+ cells from cancer cell lines: chemotherapeutic implications.
abstract: Cancer stem cells (CSCs) are considered a subset of the bulk tumor responsible for initiating and maintaining the disease. Several surface cellular markers have been recently used to identify CSCs. Among those is CD133, which is expressed by hematopoietic progenitor cells as well as embryonic stem cells and various cancers. We have recently isolated and cultured CD133 positive [CD133+] cells from various cancer cell lines using a NASA developed Hydrodynamic Focusing Bioreactor (HFB) (Celdyne, Houston, TX). For comparison, another bioreactor, the rotary cell culture system (RCCS) manufactured by Synthecon (Houston, TX) was used. Both the HFB and the RCCS bioreactors simulate aspects of hypogravity. In our study, the HFB increased CD133+ cell growth from various cell lines compared to the RCCS vessel and to normal gravity control. We observed a +15-fold proliferation of the CD133+ cellular fraction with cancer cells that were cultured for 7-days at optimized conditions. The RCCS vessel instead yielded a (-)4.8-fold decrease in the CD133+cellular fraction respect to the HFB after 7-days of culture. Interestingly, we also found that the hypogravity environment of the HFB greatly sensitized the CD133+ cancer cells, which are normally resistant to chemo treatment, to become susceptible to various chemotherapeutic agents, paving the way to less toxic and more effective chemotherapeutic treatment in patients. To be able to test the efficacy of cytotoxic agents in vitro prior to their use in clinical setting on cancer cells as well as on cancer stem cells may pave the way to more effective chemotherapeutic strategies in patients. This could be an important advancement in the therapeutic options of oncologic patients, allowing for more targeted and personalized chemotherapy regimens as well as for higher response rates.
authors.affiliation: Department of Biochemistry and Microbiology, Joan C. Edwards School of Medicine, Marshall University, Huntington, West Virginia, United States of America.
authors.forename: Sarah E
authors.initials: SE
authors.lastname: Kelly
authors.forename: Altomare
authors.initials: A
authors.lastname: Di Benedetto
authors.forename: Adelaide
authors.initials: A
authors.lastname: Greco
authors.forename: Candace M
authors.initials: CM
authors.lastname: Howard
authors.forename: Vincent E
authors.initials: VE
authors.lastname: Sollars
authors.forename: Donald A
authors.initials: DA
authors.lastname: Primerano
authors.forename: Jagan V
authors.initials: JV
authors.lastname: Valluri
authors.forename: Pier Paolo
authors.initials: PP
authors.lastname: Claudio
mesh_terms: D000071916:AC133 Antigen; D015703:Antigens, CD; D000970:Antineoplastic Agents / Q000494:pharmacology; D019149:Bioreactors / Q000592:standards; D045744:Cell Line, Tumor; D049109:Cell Proliferation; D002469:Cell Separation / Q000379:methods*; D004354:Drug Screening Assays, Antitumor / Q000379:methods* / Q000592:standards; D006023:Glycoproteins; D006801:Humans; D018472:Hypogravity; D014411:Neoplastic Stem Cells / Q000166:cytology*; D010455:Peptides
chemical_list: D000071916:AC133 Antigen; D015703:Antigens, CD; D000970:Antineoplastic Agents; D006023:Glycoproteins; C000606023:PROM1 protein, human; D010455:Peptides
references.citation: Ernst Schering Found Symp Proc. 2006;(5):141-53
references.pmid: 17939300
references.citation: Cell Prolif. 2009 Apr;42(2):219-28
references.pmid: 19222485
references.citation: Science. 1992 Mar 27;255(5052):1707-10
references.pmid: 1553558
references.citation: Aviat Space Environ Med. 2007 Apr;78(4 Suppl):A26-37
references.pmid: 17511296
references.citation: J Cell Biochem. 2009 Jul 1;107(4):723-31
references.pmid: 19415677
references.citation: Hepatology. 2006 Jul;44(1):240-51
references.pmid: 16799977
references.citation: Proc Natl Acad Sci U S A. 2004 Jan 20;101(3):781-6
references.pmid: 14711994
references.citation: Nature. 2001 Nov 1;414(6859):105-11
references.pmid: 11689955
references.citation: J Clin Oncol. 2008 Jun 10;26(17):2890-4
references.pmid: 18539969
references.citation: Int J Artif Organs. 1999 Dec;22(12):816-22
references.pmid: 10654878
references.citation: Pediatr Res. 2006 Apr;59(4 Pt 2):59R-64R
references.pmid: 16549550
references.citation: Mol Interv. 2006 Jun;6(3):140-8
references.pmid: 16809475
references.citation: Biochim Biophys Acta. 2007 Jun;1775(2):283-97
references.pmid: 17374555
references.citation: Curr Neurol Neurosci Rep. 2007 May;7(3):215-20
references.pmid: 17488587
references.citation: Cell Prolif. 2009 Jun;42(3):385-93
references.pmid: 19397591
references.citation: Science. 1977 Jul 29;197(4302):461-3
references.pmid: 560061
references.citation: Semin Cancer Biol. 2007 Jun;17(3):214-8
references.pmid: 16750389
references.citation: Cancer. 2004 Feb 15;100(4):818-25
references.pmid: 14770440
references.citation: J Invest Dermatol. 2006 Jan;126(1):142-53
references.pmid: 16417230
references.citation: Neoplasma. 2005;52(6):435-40
references.pmid: 16284686
references.citation: Cell Mol Life Sci. 2007 Dec;64(24):3248-60
references.pmid: 17955177
references.citation: Nat Rev Cancer. 2005 Apr;5(4):275-84
references.pmid: 15803154
references.citation: J Cell Mol Med. 2008 Jan-Feb;12(1):67-96
references.pmid: 18053092
references.citation: J Neurosci. 1992 Nov;12(11):4565-74
references.pmid: 1432110
references.citation: Proc Natl Acad Sci U S A. 2003 Apr 1;100(7):3983-8
references.pmid: 12629218
references.citation: Stem Cell Rev. 2007 Jun;3(2):169-75
references.pmid: 17873349
references.citation: Cancer Res. 2003 Sep 15;63(18):5821-8
references.pmid: 14522905
references.citation: PLoS One. 2008;3(10):e3469
references.pmid: 18941626
references.citation: J Antibiot (Tokyo). 1979 Oct;32(10):1038-45
references.pmid: 528363
references.citation: Pediatr Res. 2007 Sep;62(3):239
references.pmid: 17712286
references.citation: Nat Rev Cancer. 2008 Jun;8(6):465-72
references.pmid: 18451812
references.citation: Aviat Space Environ Med. 2008 Jun;79(6):629-35
references.pmid: 18581950
references.citation: Health Phys. 2003 Jul;85(1):94-102
references.pmid: 12861962
references.citation: Trends Cell Biol. 2005 Sep;15(9):494-501
references.pmid: 16084092
references.citation: Cancer Chemother Rep. 1968 Feb;52(2):251-5
references.pmid: 5646852
references.citation: Pharm Weekbl Sci. 1985 Oct 25;7(5):173-80
references.pmid: 3906559
references.citation: J Cell Physiol. 2008 Aug;216(2):332-6
references.pmid: 18459113
references.citation: Cancer Cell Int. 2007 Sep 10;7:14
references.pmid: 17845729
references.citation: Cancer Treat Rep. 1981;65 Suppl 1:3-12
references.pmid: 7326663
references.citation: Lab Invest. 2008 May;88(5):459-63
references.pmid: 18379567
references.citation: Cancer Res. 2005 Dec 1;65(23):10946-51
references.pmid: 16322242
references.citation: J Clin Oncol. 2008 Jun 10;26(17):2883-9
references.pmid: 18539968
references.citation: J Clin Oncol. 2008 Jun 10;26(17):2862-70
references.pmid: 18539965
references.citation: Cancer Res. 2006 Jul 15;66(14):7341-7
references.pmid: 16849585
references.citation: J Clin Oncol. 2008 Jun 10;26(17):2806-12
references.pmid: 18539958
references.citation: Proc Natl Acad Sci U S A. 2004 Sep 28;101(39):14228-33
references.pmid: 15381773
references.citation: Cell Res. 2008 May;18(5):528-37
references.pmid: 18414448
references.citation: Biotechnol Bioeng. 2009 Mar 1;102(4):1242-50
references.pmid: 18949761
references.citation: J Surg Oncol. 2001 Nov;78(3):162-70
references.pmid: 11745799
references.citation: Mutat Res. 1999 Dec 6;430(2):255-69
references.pmid: 10631340
references.citation: Adv Space Res. 1992;12(2-3):195-200
references.pmid: 11537008
references.citation: J Natl Compr Canc Netw. 2007 Apr;5(4):449-55
references.pmid: 17442235
references.citation: J Orthop Res. 2009 Apr;27(4):517-21
references.pmid: 18932231
references.citation: Neoplasia. 2005 Nov;7(11):967-76
references.pmid: 16331882
references.citation: Gene Ther. 2008 Nov;15(21):1446-53
references.pmid: 18596829
references.citation: Cancer Invest. 2001;19(3):292-315
references.pmid: 11338887
references.citation: J Pathol. 2008 Jan;214(1):3-9
references.pmid: 18067118
references.citation: Ann N Y Acad Sci. 2006 Dec;1091:470-89
references.pmid: 17341637
references.citation: Expert Rev Mol Diagn. 2008 Jul;8(4):387-93
references.pmid: 18598221
references.citation: Stem Cell Rev. 2008 Sep;4(3):211-6
references.pmid: 18663609